Ciel Pharma SRL
Ouverture de failliteCiel Pharma reported total assets of €1.62m at the end of the 2024 financial year (annual accounts filed with the NBB on 14 Nov 2025).
By total assets for 2024, Ciel Pharma ranks among the 1,000 largest of the 3,821 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Ciel Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +124 % Total assets +28 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ciel Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 14 Nov 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 18 Dec 2023
- Year ended 31 Dec 2021filed on 24 Nov 2022
- Year ended 31 Dec 2020filed on 24 Aug 2021
Ciel Pharma's financial analysis
- Solvency10.3%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ciel Pharma
Ciel Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0690.987.220
- VAT number
- BE0690987220
- Peppol
- Registered · 0208:0690987220 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Feb 2018
- Registered office
- 1050 Brussels
- Latest accounts
- 2024 · filed on 14 Nov 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Ciel Pharma (SRL) has been based in Brussels since 2018, active in: retail sale of pharmaceutical products. For 2024, it reports a net profit of 15,001 € and equity of 166,036 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Ciel Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmabrussels Flagey Retail sale of pharmaceutical products Ixelles · balance sheet €1.20m
- Pharmacie du Petit Courcelles Retail sale of pharmaceutical products Courcelles · balance sheet €1.64m
- Apotheek Bytebier-Van Antwerpen Retail sale of pharmaceutical products Aartselaar · balance sheet €1.79m
- Humbeek Pharma Retail sale of pharmaceutical products Grimbergen · balance sheet 653,604 €
- Vereenooghe LDL Retail sale of pharmaceutical products Lendelede · balance sheet 377,699 €
- Blauwblomme Retail sale of pharmaceutical products Kortrijk · balance sheet 559,420 €
- Pharm-OZ Retail sale of pharmaceutical products Charleroi · balance sheet 681,585 €
- Koltfarma Retail sale of pharmaceutical products Charleroi · balance sheet 488,225 €
Frequently asked questions about Ciel Pharma
What is the revenue of Ciel Pharma?
Ciel Pharma files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Ciel Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0690987220 for Ciel Pharma, if the company is VAT-registered. Its company number (CBE) is 0690.987.220.
Where is the registered office of Ciel Pharma?
According to the CBE register, the registered office of Ciel Pharma is in 1050 Brussels.
What is the equity of Ciel Pharma?
At the close of the 2024 financial year, the equity of Ciel Pharma amounts to 166,036 €, a solvency of 10.3% of total assets.
Who manages Ciel Pharma?
The register lists 2 active mandates at Ciel Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Ciel Pharma within its sector?
By total assets for 2024, Ciel Pharma ranks among the 1,000 largest of the 3,821 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.
The full file of Ciel Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →